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Abstract 
It is widely believed that assays of platelet activation are susceptible to pre-analytical 
variables related to blood draw technique. We assessed platelet activation by whole blood 
flow cytometry and investigated the effects of: 1) drawing blood into vacuum tubes or 
manually-aspirated syringes, and 2) discarding the first drawn blood sample (discard tube). 
Platelet P-selectin expression and platelet-monocyte complexes were measured by flow 
cytometry under both basal conditions and following stimulation with 0.1, 1 or 10µM ADP. 
Bland-Altman plots demonstrated agreement between results for vacuum tube and syringe-
aspirated samples with an a priori-defined clinically relevant agreement limit of 5%. 
Agreement of results was also observed between discard tube and second draw samples for 
both vacuum-driven and manually aspirated blood. We conclude that a vacuum tube or a 
manually-aspirated syringe can be used when assessing platelet activation by flow cytometry 
and that there is no need for a discard tube. 
 
Keywords: blood collection; preanalytical variability; flow cytometry; platelets; agreement 
statistics  
 
 
 
 
Introduction 
Unresponsiveness or hyper-reactivity of platelets can lead to disease, and assays of platelet 
function are commonly used diagnostically and experimentally. Since platelets are prone to 
become artificially activated ex vivo, rigorous attention is given to pre-analytical variables [1], 
particularly the technique used for blood collection [2]. Guidelines for the diagnostic 
evaluation of platelet disorders recommend either vacuum- or syringe-driven aspiration of 
blood into primary collection tubes [3]. However, many authorities believe that vacuum 
systems subject blood to higher levels of shear stress, resulting in artificial platelet activation 
[4]. Furthermore, the Clinical Laboratory Standards Institute (CLSI) recommends discarding 
the first drawn tube when blood is taken through a butterfly needle [5]. The rationale is that 
dead space in the tubing leads to underfilling of the primary collection tube leading to an 
incorrect anticoagulant/blood ratio [6,7].  
 
Flow cytometry allows rapid ex vivo measurement of platelet activation through the 
assessment of surface receptors such as P-selectin, platelet-monocyte complexes, or 
fibrinogen binding [8].  Upon platelet stimulation, P-selectin from α-granules is rapidly 
translocated to the platelet membrane where it can be detected using labelled antibodies. 
Surface P-selectin mediates the rolling of platelets on endothelial cells, facilitates interactions 
with monocytes, and enables the initial platelet-platelet contacts needed for platelet 
aggregation [9]. P-selectin expression is often used as the ‘gold standard’ for assessing 
platelet activation, yet it can be rapidly shed from the platelet membrane so functional assays 
such as measurement of platelet-monocyte complexes are also performed [10].  
 
The effect of pre-analytical variables on platelet activation assessed by flow cytometry has 
only been partially evaluated [11]. We, therefore, investigated the effect of blood draw 
technique on basal and stimulated P-selectin expression and platelet-monocyte complexes 
measured by whole blood flow cytometry. We applied statistical methods for assessing 
agreement between different techniques.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods  
 
Patients and specimens  
The study population comprised ten healthy volunteers (four males and six females; mean 
age 26), recruited from University staff who had not taken platelet-altering medication for a 
minimum of 14 days. The study was approved by the Ethics Committee of Hull York Medical 
School. Two consecutive blood samples (Vac-1 and Vac-2) were drawn from the from the 
median cubital vein in the right arm using a 21g butterfly needle (Becton Dickinson, UK) into 
2.7 ml Vacutainers® containing 0.109 mol/l buffered sodium citrate (Becton Dickinson, UK). 
Immediately, two consecutive 2.7 ml samples (Syr-1 and Syr-2) were drawn from the opposing 
arm by manual aspiration into 5.0 ml syringes preloaded with 0.109 mol/l buffered sodium 
citrate. Other variables including tourniquet tightness and rest time were standardised. 
Samples were processed within 20 minutes of venepuncture and flow cytometry performed 
within 3 hours.  
 
Laboratory tests 
40µl of whole blood was incubated at room temperature for 20 minutes in 40µl phosphate-
buffered saline (PBS) containing anti-CD14-APC (4µL), anti-CD42b-AF488 (4µL) (BioLegend) 
and varying concentrations of adenosine diphosphate (0.1, 1 and 10μM ADP) (4µL). 800µL of 
FACS™ Lysing solution (BD Biosciences, UK) was added before performing two colour flow 
cytometry (BD FACSCalibur™). Monocytes were identified by their forward and side scatter 
properties and CD14 expression. The percentage of CD14+ monocytes forming platelet-
monocyte complexes (CD14+ CD42b+) was calculated.  
 20µl of whole blood was incubated at room temperature for 20 minutes in 20µl PBS 
containing anti-CD62P-PE (6µl) (BioLegend) and varying concentrations of ADP (0.1, 1 and 
10μM) (2µL). A separate sample was incubated in anti-CD42b-PerCP-Cy5.5 (BioLegend) (2µL) 
to confirm that the gated population was platelets. Samples were fixed with 400µL of 1% 
paraformaldehyde before flow cytometric analysis. Platelets were identified by their forward 
and side scatter properties and CD42b expression. 10,000 platelet events were acquired. We 
recorded the mean fluorescence intensity (MFI) and the percentage of platelets expressing 
CD62P with the positive region marker set at the 99th percentile of the isotype antibody 
fluorescence.  
 
Statistical analysis  
We used XLSTAT (Addinsoft, Paris, France), MedCalc version 18.2.1 (Ostend, Belgium) and 
GraphPad Prism version 7 (GraphPad Software, CA, USA) for statistical analyses. 
Measurements are reported as mean and 95% confidence internal (95% CI). Comparisons for 
Syr-1 vs Syr-2, Vac-1 vs Vac-2, Syr-1 vs Vac-1 and Syr-2 vs Vac-2 were performed using 
Pearson’s correlation alongside Passing and Bablock regression. The Shapiro Wilk test 
confirmed normality of the differences between each of the pairs. Paired students t-tests 
assessed the significance of differences between samples and Bonferroni correction was 
employed for multiple testing. Bland-Altman plots were generated to assess agreement 
between the pairs for both platelet-monocyte complexes and platelet P-selectin expression 
[12]. The a priori acceptable agreement between methods was set at 5%. Further explanation 
of the statistical approach can be found in the supplementary information. 
 Results  
Stimulation with ADP caused concentration-dependent increases in platelet-monocyte 
complexes and platelet P-selectin expression (Fig. S1). When comparing the different blood 
draw methods, Pearson’s correlation coefficients (PCCs) ranged from 0.984-0.993 for platelet-
monocyte complexes and 0.977-0.988 for platelet P-selectin expression. Passing and Bablock 
regression slopes were close to unity for Syr-1-Syr-2 (1.00, 0.989), Vac-1-Vac-2 (1.02, 0.979), 
Syr-1-Vac-1 (0.996, 0.953), Syr-2-Vac-2 (1.01, 0.963) for platelet-monocyte complexes and P-
selectin expression respectively (Table S1). Differences between P-selectin expression 
(percent positive) and percentage platelet-monocyte complexes between samples were not 
statistically significant at any ADP concentration (Table I). Furthermore, no statistical 
significance was seen between P-selectin MFI at any ADP concentration (Table S2). When 
assessing agreement between methods using Bland-Altman plots, good agreement was 
demonstrated by the 95% limits of agreement (LOA) and the a priori 5% agreement limit for 
platelet-monocyte complexes and platelet P-selectin expression for all comparisons (Fig 1). 
Higher variability was seen between methods at higher levels of ADP stimulation 
(proportional bias) but was bidirectional and within acceptable limits (Fig 1). 
 
 
 
 
 
 Discussion  
Evidence suggests that the pre-analytical stage is most vulnerable to laboratory error [13].  
Although guidelines exist for the standardisation of pre-analytical variables when conducting 
platelet assays, recommendations are based on light-transmission aggregometry and the 
platelet function analyser-100 with no data arising from flow cytometric studies [3].  
 
Bland-Altman plots allow systematic differences to be detected between two measurement 
techniques [12].  Studies investigating the influence of pre-analytical variables on platelet 
assays suffer from inappropriate statistical analysis [6,14]. Moreover, failure to define a priori 
clinically meaningful differences hampers interpretation of Bland-Altman plots [15,16]. In the 
present study, we display Bland-Altman plots displaying a priori clinically meaningful 
differences and data-defined LOA.  
 
Guidelines advocate that a discard tube of blood is needed when a butterfly device is used 
[5]. We demonstrate agreement in basal and stimulated platelet P-selectin expression and 
platelet-monocyte complexes between the first and second collection tubes. We conclude it 
is unnecessary to discard the first tube of blood drawn.  
 
Agreement was also established between results of blood aspiration via syringe or vacuum 
tube, which is consistent with guidance that blood may be drawn by either method [3]. 
 The present study represents the first attempt to apply agreement statistics to pre-analytical 
determinants of platelet activation assessed by flow cytometry. We have shown that the 
initial blood drawn, or subsequent samples drawn by butterfly needle into a vacuum tube or 
manual syringe, did not influence platelet activation assessed by flow cytometry. 
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Figure and Table Legend 
 
Table I.  
Difference in percentage of platelet-monocyte complexes and percentage of platelets 
positive for P-selectin under basal and stimulated conditions, in whole blood collected into 
either BD Vacutainers containing 0.109mol/l buffered sodium citrate or manual syringes 
preloaded with 0.109mol/l buffered sodium citrate. *Mean difference for paired 
observations. Syr: syringe driven aspiration; Vac: vacutainer driven aspiration; ADP: 
adenosine diphosphate. Values are shown as mean and 95% CI. Significance at P<.00125 (after 
Bonferroni correction).  
 
Fig 1. 
Bland-Altman plots of agreement for percentage platelet-monocyte complexes (a-d) and 
percentage P-selectin expression (e-h) between (a, e) Syr-1 and Syr-2, (b, f) Vac-1 and Vac-2, 
(c, g) Syr-1 and Vac-1, (d, h) Syr-2 and Vac-2. Horizontal blue lines and dotted red lines 
represent the mean difference between the two collection methods and the 95% limits of 
agreement (LOA) respectively. Horizontal green lines represent the a priori maximum allowed 
difference of ±5% between methods. Vertical error bars represent 95% Cis for the LOA. Syr: 
syringe driven aspiration; Vac: vacutainer driven aspiration. 
 
 
 
Table I 
 
Percentage Platelet-Monocyte Complexes 
 
ADP 
Concentration 
(µM)  
 
Syr-1 
 
Syr-2 
 
Vac-1 
 
Vac-2 
 
Syr-1 vs Syr-2 
 
Vac-1 vs Vac-2 
 
Syr-1 vs Vac-1 
 
Syr-2 vs Vac-2 
  
 
 
Values  
 
 
 
Values 
 
 
 
Values  
 
 
 
Values  
% difference % difference    % difference  % difference  
 
Mean 
difference* 
(%) 
 
95% 
confidence 
interval  
 
 
P value 
 
Mean 
difference 
(%) 
 
95% 
confidence 
interval 
 
 
P value 
 
Mean 
difference 
(%) 
 
95% 
confidence 
interval 
 
 
P value 
 
Mean 
difference 
(%) 
 
95% 
confidence 
interval 
 
 
P value 
Basal 7.27 
 (6.47, 8.07) 
7.26 
(6.42, 8.10) 
7.10 
(6.2,7.99) 
7.06 
(6.37, 7.76) 0.010 
(-1.22, 
1.24) 0.986 0.037 
(-0.585, 
0.659) 0.896 0.173 
(-0.948, 
1.293) 0.735 0.200 
(-0.642, 
1.04) 0.604 
0.1 15.7 
(14.6, 16.9) 
14.9 (13.7, 
16.2) 
16.0 (14.6, 
17.4) 
15.9 (14.8, 
17.0) 0.767 
(-0.688, 
2.22) 0.263 0.133 
(-0.912, 
1.18) 0.780 -0.310 
(-2.014, 
1.394) 0.690 -0.944 
(-3.08, 
1.19) 0.343 
1 
48.4  
(46.4, 50.3) 
46.74 
(44.7, 48.7) 
48.8  
(47.4, 50.2) 
48.9  
(46.7, 51.2) 1.62 
(-1.28, 
4.53) 0.238 -0.108 
(-2.09, 
1.88)  0.905 -0.464 
(-3.383, 
2.455) 0.727 -2.19 
(-5.17, 
0.785) 0.130 
10 75.2  
(73.4, 77.1) 
75.6  
(74.0, 77.1) 
74.3 
 (72.4, 76.3) 
73.4  
(71. 8, 75.1) -0.325 
(-2.28, 
1.63) 0.716 0.904 
(-1.57, 
3.38) 0.430 0.903 
(-2.586, 
4.392) 0.573 2.13 
(-0.751, 
5.02) 0.129 
Combined 
 0.519 
(-0.372, 
1.41) 0.246 0.242 
(-0.499, 
0.982) 0.513 0.076 
(-1.009, 
1.160) 0.889 -0.202 
(-1.34, 
0.939) 0.723 
                                                                                                                                                                
Percentage Platelets positive for P-selectin 
 
Basal 2.74 
 (2.23, 3.24) 
2.88  
(2.40, 3.37) 
2.67 
(2.23, 3.11) 
2.67 
(2.10, 3.24) -0.146 
(-0.528, 
0.236) 0.409 0.003 
(-0.552, 
0.558) 0.991 0.067 
(-0.282, 
0.416) 0.674 0.216 
(-0.035, 
0.467) 0.083 
0.1 5.20  
(4.38, 6.03) 
5.42  
(4.69, 6.14) 
5.20  
(4.48, 5.93) 
5.35  
(4.48, 6.22) -0.212 
(-0.608, 
0.184) 0.256 -0.144 
(-0.508, 
0.220) 0.393 -0.001 
(-0.349, 
0.347) 0.995 0.067 
(-0.592, 
0.726) 0.823 
1 22.2 
 (19.5, 24.9) 
23.0  
(20.3, 25.7) 
25.3  
(22.2, 28.5) 
24.9 
 (21.8, 27.9) -0.862 
(-2.99, 
1.27) 0.383 0.463 
(-0.797, 
1.72) 0.427 -3.162 
(-4.753, -
1.57) 0.002 -1.84 
(-3.16, -
0.515) 0.012 
10 49.0  
(44.2, 53.9) 
48.1  
(42.7, 53. 6) 
48.8  
(43.4, 54.3) 
49.6  
(44.6, 54.6) 0.933 
(-2.47, 
4.34) 0.551 -0.794 
(-3.50, 
1.91) 0.524 0.193 
(-3.20, 
3.58) 0.900 -1.53 
(-4.57, 
1.51) 0.283 
Combined  
-0.072 
(-0.967, 
0.824) 0.872 -0.118 
(-0.791, 
0.555) 0.725 -0.726 
(-1.66, 
0.205) 0.123 -0.772 
(-1.56, 
0.015) 0.052 
 
Fig 1  
 
 
(a) (b) 
(c) (d) 
(e) (f) 
(g) (h) 
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Methods  
Statistical Approach  
To assess agreement a stepwise approach was undertaken. Although it is assumed that two 
techniques for measuring the same output will be closely related, Pearson’s correlation 
coefficient (PCC) was calculated to clarify the presence of a linear relationship between Syr-
1-Syr-2, Vac-1-Vac-2, Syr-1-Vac-1, Syr-2-Vac-2. PCC is highly sensitive to the range of values 
and lacks information about systematic difference therefore PCC does not assess agreement 
as a high degree of correlation is possible when agreement is poor [1].  Passing and Bablock 
regression analysis was then undertaken on the above pairs. This is a non-parametric linear 
regression procedure which is non-sensitive to outliers and fits the parameters of a and b in 
the linear equation y = a + bx. This reveals constant (regression line intercept a) and 
proportional (regression line slope b) difference with confidence intervals of 95% (95% Cis). 
Therefore, if the 95% Cis for a include zero one can conclude that there is no constant 
difference between methods. Additionally, if the 95% Cis for b include the value one, then it 
can be concluded that there is no proportion difference between methods. Overall this allows 
the for the assumption that x = y and agreement between methods to be presumed. The 
primary fallacy with the Passing and Bablock regression model is that it derives the agreement 
of two methods from the data and neglects whether this is within clinically relevant 
parameters [2]. Therefore, Bland-Altman analysis was undertaken (explained in the main text) 
to assess whether the agreement between the above pairs was within an a priori 5% 
agreement limit. With this analysis, a paired students t-test was also computed testing the 
null hypothesis H0 that the mean of the differences between the results does not differ from 
0, against the alternative Ha that it does. Finally, Bonferroni correction was applied to adjust 
the significant p value for paired students t-tests to account for multiple comparisons. 
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Figure Legend for Supplementary Tables 
Table SI. 
Results of Passing and Bablock regression analysis for Syr-1 vs Syr-2, Vac-1 vs Vac-2, Syr-1 vs 
Vac-1 and Syr-2 vs Vac-2 for percentage platelet-monocyte complexes and percentage 
platelet P-selectin expression. Syr: syringe driven aspiration; Vac: BD vacutainer™ driven 
aspiration 
 
Table S2. 
Platelet P-selectin mean fluorescent intensity (MFI) under basal and stimulated conditions, 
in whole blood collected into either BD Vacutainers containing 0.109mol/l buffered sodium 
citrate or manual syringes preloaded with 0.109mol/l buffered sodium citrate. Syr: syringe 
driven aspiration; Vac: vacutainer driven aspiration; ADP: adenosine diphosphate. Values 
are shown as mean and 95% CI. Significance at P<.00125 (after Bonferroni correction). 
 
Figure Legend for Supplementary Figure  
Fig S1.  
Platelet activation status as expressed by platelet-monocyte complexes (a) or platelet P-
selectin expression (b) under basal conditions and when stimulated with 0.1μM ADP, 1μM 
ADP, 10μM ADP in both manual syringe and vacuum-aspirated blood. Syr: syringe driven 
aspiration; Vac: BD vacutainer™ driven aspiration; ADP: adenosine diphosphate. Data are 
expressed as mean and 95% confidence interval. 
 
Table SI. 
 
  Intercept   95% CI Slope 95% CI 
% Platelet-
Monocyte 
Complexes 
 
Syr-1 vs Syr-2 
0.614 
 
-0.384 to 
1.328 
1.000 
 
0.967 to 
1.047 
 
 
Vac-1 vs Vac-2 
-0.302 
 
-1.389 to 
0.558 
 
1.020 
 
0.978 to 
1.053 
 
 
Syr-1 vs Vac-1 
-0.133 
 
-1.403 to 
1.152 
 
0.996 
 
0.940 to 
1.047 
 
 
Syr-2 vs Vac-2 
-0.795 
 
-2.014 to 
0.901 
 
1.010 
 
0.961 to 
1.073 
 
% Platelet P-
selectin 
expression 
 
Syr-1 vs Syr-2 
-0.243 
 
-0.650 to 
0.203 
 
0.989 
 
0.926 to 
1.054 
 
 
Vac-1 vs Vac-2 
0.068 
 
-0.250 to 
0.457 
 
0.979 
 
0.951 to 
1.036 
 
 
Syr-1 vs Vac-1 
0.021 
 
-0.345 to 
0.514 
0.953 
 
0.895 to 
1.013 
 
 
Syr-2 vs Vac-2 
0.412 
 
0.080 to 
0.793 
 
0.933 
 
0.898 to 
0.979 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2 
 
MFI Platelet P-selectin expression  
 
ADP 
Concentration 
(µM)  
 
Syr-1 
 
Syr-2 
 
Vac-1 
 
Vac-2 
 
Syr-1 vs Syr-2 
 
Vac-1 vs Vac-2 
 
Syr-1 vs Vac-1 
 
Syr-2 vs Vac-2 
  
Values 
 
Values 
 
Values 
 
Values 
 
P value 
 
P value 
 
P value 
 
P value 
Basal 30.6 
(29.0, 32.1) 
30.1 
(28.4, 31.8) 
30.0 
(27.8, 32.3) 
30.1 
(28.4, 31.7) 0.610 0.969 0.498 0.948 
0.1 39.8 
(38.1, 41.4) 
38.8 
(37.4, 40.2) 
41.2 
(38.3, 44.2) 
39.9 
(38.6, 41.2) 0.292 0.379 0.289 0.249 
1 
74.6 
(72.4, 76.9) 
73.6 
(71.4, 75.9) 
77.0 
(75.3, 78.6) 
73.9 
(71.9, 75.9) 0.541 0.116 0.186 0.065 
10 145 
(145, 150) 
145 
(143, 147) 
145 
(145, 150) 
146 
(145, 149) 0.097 0.433 0.919 0.135 
Fig S1 
 
 
 
 
 
(a) (b) 
